Literature DB >> 29517905

Neutron Crystallography Detects Differences in Protein Dynamics: Structure of the PKG II Cyclic Nucleotide Binding Domain in Complex with an Activator.

Oksana Gerlits1, James C Campbell2, Matthew P Blakeley3, Choel Kim2,4, Andrey Kovalevsky5.   

Abstract

As one of the main receptors of a second messenger, cGMP, cGMP-dependent protein kinase (PKG) isoforms I and II regulate distinct physiological processes. The design of isoform-specific activators is thus of great biomedical importance and requires detailed structural information about PKG isoforms bound with activators, including accurate positions of hydrogen atoms and a description of the hydrogen bonding and water architecture. Here, we determined a 2.2 Å room-temperature joint X-ray/neutron (XN) structure of the human PKG II carboxyl cyclic nucleotide binding (CNB-B) domain bound with a potent PKG II activator, 8-pCPT-cGMP. The XN structure directly visualizes intermolecular interactions and reveals changes in hydrogen bonding patterns upon comparison to the X-ray structure determined at cryo-temperatures. Comparative analysis of the backbone hydrogen/deuterium exchange patterns in PKG II:8-pCPT-cGMP and previously reported PKG Iβ:cGMP XN structures suggests that the ability of these agonists to activate PKG is related to how effectively they quench dynamics of the cyclic nucleotide binding pocket and the surrounding regions.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29517905      PMCID: PMC5890435          DOI: 10.1021/acs.biochem.8b00010

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  21 in total

1.  The amino-terminal cyclic nucleotide binding site of the type II cGMP-dependent protein kinase is essential for full cyclic nucleotide-dependent activation.

Authors:  M K Taylor; M D Uhler
Journal:  J Biol Chem       Date:  2000-09-08       Impact factor: 5.157

Review 2.  cGMP-dependent protein kinases in drug discovery.

Authors:  Jens Schlossmann; Franz Hofmann
Journal:  Drug Discov Today       Date:  2005-05-01       Impact factor: 7.851

3.  Room Temperature Neutron Crystallography of Drug Resistant HIV-1 Protease Uncovers Limitations of X-ray Structural Analysis at 100 K.

Authors:  Oksana Gerlits; David A Keen; Matthew P Blakeley; John M Louis; Irene T Weber; Andrey Kovalevsky
Journal:  J Med Chem       Date:  2017-02-28       Impact factor: 7.446

4.  Mechanism of cAMP Partial Agonism in Protein Kinase G (PKG).

Authors:  Bryan VanSchouwen; Rajeevan Selvaratnam; Rajanish Giri; Robin Lorenz; Friedrich W Herberg; Choel Kim; Giuseppe Melacini
Journal:  J Biol Chem       Date:  2015-09-14       Impact factor: 5.157

5.  Crystal structure of cGMP-dependent protein kinase Iβ cyclic nucleotide-binding-B domain : Rp-cGMPS complex reveals an apo-like, inactive conformation.

Authors:  James C Campbell; Bryan VanSchouwen; Robin Lorenz; Banumathi Sankaran; Friedrich W Herberg; Giuseppe Melacini; Choel Kim
Journal:  FEBS Lett       Date:  2016-12-23       Impact factor: 4.124

6.  Structural basis for cyclic-nucleotide selectivity and cGMP-selective activation of PKG I.

Authors:  Gilbert Y Huang; Jeong Joo Kim; Albert S Reger; Robin Lorenz; Eui-Whan Moon; Chi Zhao; Darren E Casteel; Daniela Bertinetti; Bryan Vanschouwen; Rajeevan Selvaratnam; James W Pflugrath; Banumathi Sankaran; Giuseppe Melacini; Friedrich W Herberg; Choel Kim
Journal:  Structure       Date:  2013-11-14       Impact factor: 5.006

Review 7.  cGMP regulated protein kinases (cGK).

Authors:  Franz Hofmann; Dominik Bernhard; Robert Lukowski; Pascal Weinmeister
Journal:  Handb Exp Pharmacol       Date:  2009

8.  Joint X-ray/neutron crystallographic study of HIV-1 protease with clinical inhibitor amprenavir: insights for drug design.

Authors:  Irene T Weber; Mary Jo Waltman; Marat Mustyakimov; Matthew P Blakeley; David A Keen; Arun K Ghosh; Paul Langan; Andrey Y Kovalevsky
Journal:  J Med Chem       Date:  2013-06-28       Impact factor: 7.446

Review 9.  Cyclic GMP-dependent protein kinases and the cardiovascular system: insights from genetically modified mice.

Authors:  Robert Feil; Suzanne M Lohmann; Hugo de Jonge; Ulrich Walter; Franz Hofmann
Journal:  Circ Res       Date:  2003-11-14       Impact factor: 17.367

10.  Neutron diffraction reveals hydrogen bonds critical for cGMP-selective activation: insights for cGMP-dependent protein kinase agonist design.

Authors:  Gilbert Y Huang; Oksana O Gerlits; Matthew P Blakeley; Banumathi Sankaran; Andrey Y Kovalevsky; Choel Kim
Journal:  Biochemistry       Date:  2014-10-22       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.